IBCP
Independent Bank Corporation
IBCP's outlook is improving, though it still trails on the overall score.
JPM
JPMorgan Chase & Co.
JPM has the edge over IBCP overall, supported by stronger fundamentals and stronger modeled upside.
IBCP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
IBCP's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like IBCP.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
IBCP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $23.36 | -36% |
| Fair | 8.4x | $28.55 | -22% |
| Forward | 9.4x | $36.58 | — |
| Expensive | 11x | $36.35 | -0.6% |
| Current | 11x | $36.58 | — |
Historical ranges are pointers, not guarantees.
IBCP's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 9.4x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over IBCP in the historical PE scenario, which offers more potential upside but is not a forecast.
IBCP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for IBCP, with profitability holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
IBCP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.88 | +14% |
| Q3 2026 | $3.40 | +4.3% |
| Q2 2026 | $3.44 | +12% |
| Q1 2026 | $3.35 | +6.7% |
| Q4 2025 | $3.28 | +3.8% |
| Q3 2025 | $3.26 | +11% |
| Q2 2025 | $3.07 | -1.6% |
| Q1 2025 | $3.14 | +6.8% |
| Q4 2024 | $3.16 | +13% |
IBCP earned $3.40 per share over the past year, up 4.3% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over IBCP on earnings, with more consistent year-over-year improvement.
IBCP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.1M | +24% |
| Q2 2026 | $63.2M | +13% |
| Q1 2026 | $58.9M | +8.9% |
| Q4 2025 | $58.3M | -5.9% |
| Q3 2025 | $57.3M | +12% |
| Q2 2025 | $55.9M | -1% |
| Q1 2025 | $54.1M | +2.6% |
| Q4 2024 | $62M | +26% |
IBCP's revenue is growing: $71M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -6.7 points |
| Q2 2026 | 36% | -1.1 points |
| Q1 2026 | 34% | -1 points |
| Q4 2025 | 35% | -1.9 points |
| Q3 2025 | 37% | +3.3 points |
| Q2 2025 | 37% | -4 points |
| Q1 2025 | 35% | -2.2 points |
| Q4 2024 | 37% | +0.3 points |
IBCP's operating margin was 30% last quarter, down 6.7 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over IBCP on profitability, with a higher operating margin.
IBCP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.1M | +34% |
| Q2 2026 | $16.7M | +0.2% |
| Q1 2026 | -$13.8M | -145% |
| Q4 2025 | $6.4M | -49% |
| Q3 2025 | $16.5M | +5.3% |
| Q2 2025 | $16.7M | +139% |
| Q1 2025 | $30.6M | +52% |
| Q4 2024 | $12.4M | -19% |
IBCP has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
IBCP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.4% | +1.5M shares |
| 1 year | +7.9% | +1.6M shares |
| 3 years | +6.8% | +1.4M shares |
| 5 years | +3.9% | +831K shares |
| Available history | -2.4% | -547K shares |
IBCP has 22M diluted shares, up 7.9% from a year ago, despite $9M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.2M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $4.7M |
| Q3 2025 | $413,000 |
| Q2 2025 | $7.3M |
| Q1 2025 | $33,000 |
| Q4 2024 | — |
IBCP spent $9M buying back its own shares over the past year, up 13% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over IBCP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
IBCP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 0.1x | Very low |
IBCP has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
IBCP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 43.7 | Neutral |
IBCP's weekly RSI is 53 (neutral) and its Stochastic is 44 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
IBCP PE vs Financial Services Sector
| Metric | IBCP | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 85 | 63 | 22 pts above |
IBCP has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
IBCP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1% above |
| 20 week MA | $36.7 | 0.4% below |
| 50 week MA | $35.3 | 3.8% above |
| 100 week MA | $33.7 | 8.5% above |
| 200 week MA | $29.1 | 26% above |
IBCP's trend is mixed: it's above four of its five weekly moving averages, and 26% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
IBCP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.6 | $18.6 | -18% |
| 2021 | $18.6 | $23.3 | +25% |
| 2022 | $23.3 | $24.2 | +4% |
| 2023 | $24.2 | $26.0 | +7.4% |
| 2024 | $26.0 | $34.7 | +33% |
| 2025 | $34.7 | $33.1 | -4.5% |
| 2026 YTD | $33.1 | $36.6 | +10% |
IBCP has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.